Michael Schubert

Could a new image analysis technique contribute to earlier or more accurate diagnosis of AMD?

Patients with myopia often get poorer results from accommodating IOLs than those without – and a recent study explains why

For retina stem cell researchers, growing and purifying lots of RGCs from hPSCs has been hard… until now

Marine mammals have tear films filled with interesting antimicrobial agents – and understanding the compounds present might one day lead to new antibiotic drugs

A retrospective study by the Neuromyelitis Optica Study Group helps physicians better understand the challenging disease

5-year ATOM2 trial data confirms that 0.01% atropine is more effective at slowing myopia progression than 0.1% and 0.5% doses

A new matrix therapy agent may promote corneal healing after epi-off CXL, improving patient comfort and recovery times

Glaukos submits iDose IND to the FDA, Allergan bimatoprost implant shows promise, and ALPHAEON makes three deals in as many weeks

Placental growth factor inhibitors might show efficacy in treating dry AMD as well as wet. Might aflibercept be repurposed?

Pfizer and Allergan are to combine to form the world’s biggest pharma company, an eyecare behemoth – with a lower tax bill